BHOWMICK NEIL (Chief Scientific Officer) received a stock award from KAIROS PHARMA, LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/7/2025ACC: 0001641172-25-002927
Officer· Chief Scientific Officer
Since Sep 2024
+14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
14K acquired
Non-Derivative Transactions1
COMMON STOCK
Direct
Shares
+14K
Price / share
—
Trade value
—
% of position
1.2%
1/1/2025
1.13M→1.14M
Total
Net shares
+14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCK Direct | 1/1/2025 | A · Award | +14K | — | — | 1.2% | 1.13M | 1.14M |
| Total | +14K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported